by Megan Redshaw, Childrens Health Defense:
VAERS data released Friday by the Centers for Disease Control and Prevention show 1,357,940 reports of adverse events from all age groups following COVID-19 vaccines, including 29,790 deaths and 247,686 serious injuries between Dec. 14, 2020, and July 22, 2022.
TRUTH LIVES on at https://sgtreport.tv/
VAERS is the primary government-funded system for reporting adverse vaccine reactions in the U.S.
The data included a total of 29,790 reports of deaths — an increase of 155 over the previous week — and 247,686 serious injuries, including deaths, during the same time period — up 1,010 compared with the previous week.
Foreign reports are reports foreign subsidiaries send to U.S. vaccine manufacturers. Under U.S. Food and Drug Administration (FDA) regulations, if a manufacturer is notified of a foreign case report that describes an event that is both serious and does not appear on the product’s labeling, the manufacturer is required to submit the report to VAERS.
Of the 13,805 U.S. deaths reported as of July 22, 7% occurred within 24 hours of vaccination, 15% occurred within 48 hours of vaccination and 54% occurred in people who experienced an onset of symptoms within 48 hours of being vaccinated.
In the U.S., 601 million COVID-19 vaccine doses had been administered as of July 20, including 355 million doses of Pfizer, 227 million doses of Moderna and 19 million doses of Johnson & Johnson (J&J).
Every Friday, VAERS publishes vaccine injury reports received as of a specified date. Reports submitted to VAERS require further investigation before a causal relationship can be confirmed.
Historically, VAERS has been shown to report only 1% of actual vaccine adverse events.
U.S. VAERS data from Dec. 14, 2020, to July 22, 2022, for 6-month-olds to 5-year-olds show:
- 2,429 adverse events, including 81 cases rated as serious and 3 reported deaths.
- 4 reports of myocarditis and pericarditis (heart inflammation).
The CDC uses a narrowed case definition of “myocarditis,” which excludes cases of cardiac arrest, ischemic strokes and deaths due to heart problems that occur before one has the chance to go to the emergency department.
- 15 reports of blood clotting disorders.
- 23 reports of seizures.
U.S. VAERS data from Dec. 14, 2020, to July 22, 2022, for 5- to 11-year-olds show:
- 12,232 adverse events, including 313 rated as serious and 9 reported deaths.
The most recent reported death involves a 9-year-old girl (VAERS I.D. 2377304) from California who died two weeks after receiving her first dose of Pfizer’s COVID-19 vaccine. The child experienced abdominal pain, sore throat and chest pain during the 2-3 days before she died, according to the VAERS report, which did not indicate any pre-existing conditions.
- 24 reports of myocarditis and pericarditis.
- 47 reports of blood clotting disorders.
- 101 reports of seizures.
U.S. VAERS data from Dec. 14, 2020, to July 22, 2022, for 12- to 17-year-olds show:
- 32,835 adverse events, including 1,849 rated as serious and 44 reported deaths.
- 62 reports of anaphylaxis among 12- to 17-year-olds where the reaction was life-threatening, required treatment or resulted in death — with 97% of cases attributed to Pfizer’s vaccine.
- 657 reports of myocarditis and pericarditis with 645 cases attributed to Pfizer’s vaccine.
- 165 reports of blood clotting disorders with all cases attributed to Pfizer.
- 20 cases of postural orthostatic tachycardia syndrome (POTS) with all cases attributed to Pfizer’s vaccine.
U.S. VAERS data from Dec. 14, 2020, to July 22, 2022, for all age groups combined, show:
- 20% of deaths were related to cardiac disorders.
- 54% of those who died were male, 41% were female and the remaining death reports did not include the gender of the deceased.
- The average age of death was 73.
- As of July 22, 5,670 pregnant women reported adverse events related to COVID-19 vaccines, including 1,772 reports of miscarriage or premature birth.
- Of the 3,623 cases of Bell’s Palsy reported, 51% were attributed to Pfizer vaccinations, 40% to Moderna and 8% to J&J.
- 900 reports of Guillain-Barré syndrome, with 42% of cases attributed to Pfizer, 30% to Moderna and 27% to J&J.
- 2,293 reports of anaphylaxis where the reaction was life-threatening, required treatment or resulted in death.
- 1,743 reports of myocardial infarction.
- 14,254 reports of blood-clotting disorders in the U.S. Of those, 6,378 reports were attributed to Pfizer, 5,112 reports to Moderna and 2,718 reports to J&J.
- 4,273 cases of myocarditis and pericarditis with 2,619 cases attributed to Pfizer, 1,450 cases to Moderna and 188 cases to J&J.
- 14 cases of Creutzfeldt-Jakob disease with 8 cases attributed to Pfizer, 5 cases to Moderna and 1 case to J&J.
- 270 cases of POTS with 165 cases attributed to Pfizer, 87 cases to Moderna and 17 cases to J&J.